16
Views
53
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

A 36-Amino-Acid Region of CIITA Is an Effective Inhibitor of CBP: Novel Mechanism of Gamma Interferon-Mediated Suppression of Collagen α2(I) and Other Promoters

&
Pages 7078-7088 | Received 07 Dec 2000, Accepted 19 Jul 2001, Published online: 27 Mar 2023
 

Abstract

The class II transactivator (CIITA) is induced by gamma interferon (IFN-γ) and activates major histocompatibility complex class II; however, this report shows it suppresses other genes. An N-terminal 36 amino acids of CIITA mediates suppression of the collagen α2(I) promoter via binding to CREB-binding protein (CBP). Reconstitution of cells with CBP reverts this suppression. IFN-γ is known to inhibit collagen gene expression; to test if CIITA mediates this gene suppression, a mutant cell line defective in CIITA induction but not in the activation of STAT1/JAK/IRF-1 is studied. IFN-γ suppression of the collagen promoter and the endogenous gene is observed in the wild-type control but not in the mutant line. Suppression is restored when CIITA is introduced. Other targets of CIITA-mediated promoter suppression include interleukin 4, thymidine kinase, and cyclin D1.

ACKNOWLEDGMENTS

We thank M. Li-Weber for IL-4–CAT and TK-CAT, Albert Baldwin for CD-Luc, and R. H. Goodman for CMV5-CBP.

This study was supported by grants from the National Institutes of Health (AI45580, AI41751, AI29565, and DK38108 to J.P.-Y.T.) and the National Multiple Sclerosis Society (RG7815 to J.P.-Y.T.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.